This study underlines the importance of data collection via patient registries and the critical role of multicenter collaboration in the rare disease …
TREAT-NMD steroids analysis demonstrates the power of ‘real-world’ Registry dataRead More
February 2, 2018 by abzali123
This study underlines the importance of data collection via patient registries and the critical role of multicenter collaboration in the rare disease …
TREAT-NMD steroids analysis demonstrates the power of ‘real-world’ Registry dataRead More
January 30, 2018 by abzali123
Action Duchenne is delighted to hear the continued commitment by NHS England to improve care of those living with rare diseases. This coincides nicely …
Implementation plans for the UK Strategy for Rare DiseasesRead More
January 26, 2018 by abzali123
We are delighted to announce that the revised Standards of Care for Duchenne were published in The Lancet Neurology this week; a high-impact …
Revised Standards of Care for Duchenne muscular dystrophyRead More
January 26, 2018 by abzali123
On 14 September 2017, the CHMP of the European Medicines Agency (EMA) adopted a negative opinion, recommending the refusal of a change to the …
Santhera Receives Negative CHMP Opinion on Appeal for Authorization of Raxone® in DuchenneRead More
January 25, 2018 by abzali123
Diagnosis and management of Duchenne muscular dystrophy Part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and …
Breaking news – updated Standards of Care publishedRead More
January 25, 2018 by abzali123
Increase in utrophin protein expression observed Summit accelerating preparations for pivotal clinical trial Ezutromid is a potential …
Positive data from Summit’s PhaseOUT DMD ezutromid clinical trialRead More
January 25, 2018 by abzali123
Action Duchenne, a leading UK-wide patient and parent-led organisation for Duchenne Muscular Dystrophy, is delighted to announce the publication of a …
January 24, 2018 by abzali123
The Dubowitz Neuromuscular Centre, UCL Great Ormond Street Institute of Child Health are conducting a study which will look at anxiety in Duchenne …
Anxiety study for young people and families living with DuchenneRead More
January 23, 2018 by abzali123
It was useful to understand the services available for adults in Cardiff as well as an update on future treatments. Action Duchenne have provided a …
Families gain knowledge and support at Wales regional roundtable meetingRead More
January 18, 2018 by abzali123
Parent Project Muscular Dystrophy (PPMD) announced that the first patient has been dosed with microdystrophin gene therapy by Dr. Jerry Mendell, …
First patient dosed in microdystrophin gene therapy in USRead More
January 15, 2018 by abzali123
Join the Muscle Help Foundation at Twickenham Stadium for the England v Ireland 2-day Muscle Dream Experience. This fully hosted VIP programme is …
December 19, 2017 by abzali123
Lesley Wegg, the Maurice family and the Ward family have all held charity balls for Action Duchenne this year raising an amazing total of £30,000 …
Action Duchenne raise over £30,000 this year at charity ballsRead More
Action Duchenne
Wellesley House
Duke of Wellington Avenue Royal Arsenal
London
SE18 6SS
07535 498 506
info@actionduchenne.org